Low‐level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction
Liping Zhou(Wuhan University), Stavros Stavrakis(University of Oklahoma Health Sciences Center), Christian Fleming(University of Oklahoma Health Sciences Center), Adrian Filiberti(University of Oklahoma Health Sciences Center), Benjamin J. Scherlag(University of Oklahoma Health Sciences Center), Mary Beth Humphrey(Veterans Health Administration), Sunny S. Po(Oklahoma City University)
Cited by 74
Related Papers
Low-Level Transcutaneous Electrical Vagus Nerve Stimulation Suppresses Atrial Fibrillation
|Journal of the American College of Cardiology|2015|327
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
|Nature Genetics|2011|284
TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation)
|JACC. Clinical electrophysiology|2020|236
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
|JCI Insight|2016|226
Catheter Ablation Versus Medical Therapy for Atrial Fibrillation
|Circulation Arrhythmia and Electrophysiology|2019|222